FIELD: medicine.
SUBSTANCE: invention refers to medicine and biotechnology and represents a cell graft consisting of living cells recovered from hyaline cartilaginous tissues for treating destructive dystrophic diseases and traumatic injures of the articular cartilage, characterised by the fact that the cell graft consists of chondroblasts and fibroblast-like cell which have been grown of hyaline cartilaginous tissues of the costal cartilage and immobilised on bioresorbable three-dimensional allogenous bone carrier.
EFFECT: invention provides higher clinical effectiveness and reduced traumatism in treating destructive dystrophic diseases and traumatic injures of the articular cartilage.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CELL GRAFT FOR TREATING DISEASES AND TRAUMATIC INJURES OF ARTICULAR CARTILAGE | 2008 |
|
RU2402340C2 |
| METHOD OF COMPENSATION OF JOINT CARTILAGE DEFECTS | 2008 |
|
RU2383310C1 |
| METHOD OF USING CHONDRAL CELLS FOR SCREENING SUBSTANCES WITH ANTI-INFLAMMATORY ACTIVITY | 2018 |
|
RU2683277C1 |
| METHOD FOR SUBSTITUTION OF CARTILAGINOUS TISSUE DEFECTS | 2016 |
|
RU2637103C2 |
| METHOD OF GROWING HUMAN RETICULUM CELLS | 2009 |
|
RU2410426C2 |
| METHOD OF BIOFABRICATION OF A TRANSPLANT IN THE FORM OF CELL SPHEROIDS FOR REGENERATIVE TECHNOLOGIES FOR RESTORING A SUBJECT'S CARTILAGE BASED ON THE SUBJECT'S OWN COSTAL CARTILAGE PERICHONDRIUM AND MULTIPOTENT MESENCHYMAL STROMAL BONE MARROW CELLS OF THE SAME SUBJECT | 2022 |
|
RU2800991C2 |
| BIOTRANSPLANT FOR JOINTS CARTILAGINOUS TISSUE DEFECTS RESTORING | 2015 |
|
RU2593011C1 |
| METHOD FOR RECONSTRUCTING HYALINE ARTICULAR CARTILAGE | 2004 |
|
RU2268738C1 |
| METHOD FOR HYALINE CARTILAGE PRODUCTION | 2016 |
|
RU2627817C1 |
| METHOD OF TREATING TEMPOROMANDIBULAR JOINT ARTHROSIS | 2010 |
|
RU2440062C1 |
